Novanta Inc. NOVT
Nov 12, 2026, 11:47 AM EST
- YTD
- +0.37%
- 1 year
- +8.17%
- Market cap
- 4.52B
- Revenue (ttm)
- 1.09B
- Profit margin
- 4.89%
- EPS (ttm)
- 1.32
- Shares out
- 37.82M
- P/E ratio
- 90.47
- Forward P/E
- 28.68
- YTD return
- +0.37%
- 1-year return
- +8.17%
- Volume
- 243.76K
- Avg volume
- 416.44K
- Open
- 118.96
- Previous close
- 123.31
- Day's range
- 114.84 – 121.11
- 52-week range
- 98.27 – 176.38
- Beta
- 1.70
- Analysts
- Strong Buy
- Price target
- 194.50 (+62.9%)
- Earnings date
- Feb 22, 2027
5D -15.72 (-11.64%)
Key statistics
- Enterprise value
- 5.42B
- PEG ratio
- 0.00
- Price / sales
- 4.29
- Price / book
- 2.87
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 23.10%
- Free cash flow
- 359.97M
- Total cash
- 149.22M
- Total debt
- 894.13M
- Return on equity
- 4.38%
- Short % of float
- 15.95%
- 50-day average
- 141.80
- 200-day average
- 142.41
Analyst view
Consensus: strong buy
- Target (low)
- 194.00
- Target (mean)
- 194.50
- Target (high)
- 195.00
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 22, 2027
Expected Feb 22, 2027. Consensus EPS estimate 0.98667.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 22, 2027 | Jan 2, 2027 | 1.03 | — | — | — |
| Nov 9, 2026 | Oct 2, 2026 | 0.967 | 1.05 | +0.08 | +8.58% |
| Aug 5, 2026 | Jul 3, 2026 | 0.83 | 0.89 | +0.06 | +7.23% |
| May 11, 2026 | Apr 3, 2026 | 0.78 | 0.81 | +0.03 | +3.85% |
| Feb 23, 2026 | Dec 31, 2025 | 0.88 | 0.91 | +0.03 | +3.41% |
| Nov 3, 2025 | Sep 26, 2025 | 0.81 | 0.87 | +0.06 | +7.41% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 13, 2026 | Baird | main | Outperform | Outperform |
| Mar 30, 2026 | Baird | up | Neutral | Outperform |
| Aug 11, 2025 | Baird | main | Neutral | Neutral |
| Mar 3, 2025 | Baird | main | Neutral | Neutral |
| Nov 6, 2024 | Baird | main | Neutral | Neutral |
| Aug 7, 2024 | Baird | main | Neutral | Neutral |
About Novanta Inc.
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
- Sector
- Technology
- Industry
- Scientific & Technical Instruments
- Country
- United States
- Website
- novanta.com
News
Baird Maintains Outperform on Novanta, Lowers Price Target to $175 
Novanta Inc. (NOVT) Q3 2026 Earnings Call Transcript 
What Novanta (NOVT) Said on Its Q3 Earnings Call 
Novanta to Present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026 
Novanta (NOVT) Q3 Earnings and Revenues Surpass Estimates 
Novanta Lowers FY2026 Adj EPS Guidance from $3.68-$3.74 to $3.66-$3.71 vs $3.69 Est; Raises FY2026 Sales Guidance from $1.130B-$1.140B to $1.135B-$1.140B vs $1.134B Est 
Novanta Q3 Adj. EPS $1.05 Beats $0.97 Estimate, Sales $305.008M Beat $301.010M Estimate 
Novanta Sees Q4 Adj EPS $0.91-$0.96 vs $1.02 Est; Sees Sales $306.000M-$312.000M vs $308.823M Est 
Novanta Announces Financial Results for the Third Quarter 2026 
Here's How Much $100 Invested In Novanta 15 Years Ago Would Be Worth Today
Your note
Sign in to keep a note on NOVT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BUCKLEY ROBERT J | Chief Financial Officer | Sale | Mar 15, 2026 | 132,835 |
| BURKE JOHN JOSEPH II | Officer | Conversion of Exercise of derivative security | Feb 23, 2026 | 8,900 |
| CARPENTER LONNY J | Director | Conversion of Exercise of derivative security | Jan 1, 2026 | 5,848 |
| GLASTRA MATTHIJS | Chief Executive Officer | Sale | Jul 1, 2026 | 84,143 |
| HULIT BARBARA B | Director | Conversion of Exercise of derivative security | Jan 1, 2025 | 2,146 |
| JOHNSON ROBERT MATTHEW | Director | Conversion of Exercise of derivative security | Jan 1, 2026 | 2,143 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 12.69% | 4,798,035 | 591.65M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.33% | 2,395,681 | 295.41M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 5.88% | 2,222,445 | 274.05M | Jun 29, 2026 |
| Allspring Global Investments Holdings, LLC | 4.35% | 1,644,248 | 202.75M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.25% | 1,606,928 | 198.15M | Jun 29, 2026 |
| State Street Corporation | 3.80% | 1,436,785 | 177.17M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 1,347,475 | 166.16M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.00% | 1,132,818 | 139.69M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.48% | 938,518 | 115.73M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.16% | 817,033 | 100.75M | Jun 29, 2026 |
| VANGUARD WORLD FUND-Vanguard Information Technology Index Fund | 2.02% | 762,666 | 94.04M | Aug 30, 2026 |
| T. Rowe Price Mid-Cap Value Fund, Inc. | 2.01% | 759,889 | 93.70M | Jun 29, 2026 |